Polypharmacological Re-programming of Tumor-associated Macrophages Restores Antitumor Immunity

Nao Nishida‐Aoki(Fred Hutch Cancer Center), Taranjit S. Gujral(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
bioRxiv (Cold Spring Harbor Laboratory)
April 11, 2021
10.1101/2021.04.10.439265
Cited by 1

Related Papers

Altered biodistribution of deglycosylated extracellular vesicles through enhanced cellular uptake
|Journal of Extracellular Vesicles|2020|90
Lipidomic Analysis of Cells and Extracellular Vesicles from High- and Low-Metastatic Triple-Negative Breast Cancer
|Metabolites|2020|86
A System-Wide Investigation of the Dynamics of Wnt Signaling Reveals Novel Phases of Transcriptional Regulation
|PLoS ONE|2010|54
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming
|Cancer Discovery|2024|14
Data from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming
|Unknown|2025|3